Source: Annual Congress 2010 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Yano, K. Sogawa, M. Satoh, H. Umemura, T. Sugiura, S. Kitazono, K. Yamauchi, S. Sakao, Y. Kasahara, N. Tanabe, K. Tatsumi, F. Nomura (Japan). Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS. Eur Respir J 2010; 36: Suppl. 54, 3511

Member's Comments

No comment yet.

Related content which might interest you: Screening for biomarkers in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Plasma metabolomics in chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Source: Eur Respir J 2014; 44: 842-845 Year: 2014 Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J 2014; 44: 951-962 Year: 2014 New potential diagnostic biomarkers for pulmonary hypertension Source: Eur Respir J 2015; 46: 1390-1396 Year: 2015 Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 “New potential diagnostic biomarkers for pulmonary hypertension.” Source: Eur Respir J 2016; 48: 962 Year: 2016 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 57 (4) 2003201; 10.1183/13993003.03201-2020 Year: 2021 A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021 Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 253-262 Year: 2015